down arrow

Alivus Life

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
948.35
6.4 (0.68%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 46.14 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
P & G Health Ltd
Alivus Life
Cipla
Sun Pharma.Inds.
Granules India
Marksans Pharma
Torrent Pharma
Jubilant Ingrev.
Mankind Pharma
Sanofi Consumer
Why is Alivus Life Sciences Ltd ?
1
High Management Efficiency with a high ROE of 19.11%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Operating profit has grown by an annual rate -2.28% of over the last 5 years
4
Flat results in Dec 24
  • ROCE(HY) Lowest at 22.29 %
5
Technical trend is Sideways signifying no clear price momentum
  • The technical trend has deteriorated from Mildly Bullish on 09-Apr-25 and has generated 1.03% returns since then
6
With ROE of 17.4, it has a Fair valuation with a 4.5 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 16.60%, its profits have fallen by -15%
7
Majority shareholders : Promoters
8
Market Beating Performance
  • Even though the market (BSE 500) has generated negative returns of -0.91% in the last 1 year, the stock has been able to generate 16.60% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Alivus Life should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Drugs should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Alivus Life for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Alivus Life
16.19%
0.37
45.20%
SENSEX
0.45%
0.04
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
3.08%
EBIT Growth (5y)
-2.28%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.17
Tax Ratio
25.46%
Dividend Payout Ratio
58.54%
Pledged Shares
0
Institutional Holding
11.60%
ROCE (avg)
39.66%
ROE (avg)
19.11%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
33
Price to Book Value
4.55
EV to EBIT
19.62
EV to EBITDA
17.76
EV to Capital Employed
5.27
EV to Sales
4.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
26.12%
ROE (Latest)
17.40%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
NET SALES(Q)

Highest at Rs 641.84 cr

PBDIT(Q)

Highest at Rs 190.30 cr.

PBT LESS OI(Q)

Highest at Rs 174.69 cr.

PAT(Q)

Highest at Rs 136.96 cr.

EPS(Q)

Highest at Rs 11.18

-3What is not working for the Company
ROCE(HY)

Lowest at 22.29 %

Loading Valuation Snapshot...
Here's what is working for Alivus Life
Net Sales - Quarterly
Highest at Rs 641.84 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 190.30 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 174.69 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 174.69 cr has Grown at 27.2 %
over average PBT of the previous four quarters of Rs 137.31 Cr
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 136.96 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 136.96 cr has Grown at 29.4 %
over average PAT of the previous four quarters of Rs 105.88 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 11.18
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Alivus Life
Non Operating Income - Quarterly
Highest at Rs 10.46 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income